We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > LBP

News List

LBPs may offer hope to IBS patients in the near future, says report europeanpharmaceuticalreview
August 03, 2021
Live biotherapeutic products (LBPs) are expected to help patients with IBS who currently have no US- or EMA-approved treatments.
Recommended Therapy for Low Back Pain May Cut Lost Workdays drugs
July 07, 2021
When injured workers with low back pain (LBP) receive guideline-recommended interventions, they typically return to work sooner, according to a study published June 17 in PLOS ONE.
Bacthera Receives Manufacturing Licenses in Switzerland and Denmark firstwordpharma
June 01, 2021
Following GMP inspections by Swissmedic at Bacthera's drug product facility in Basel, Switzerland, and by the Danish Medicines Agency at Bacthera's drug substance facility in Hørsholm, Denmark, both facilities have been granted manufacturing licenses.
Sleep Disorders Up Health Care Visits, Costs for Low Back Pain drugs
July 23, 2019
The presence of a sleep disorder diagnosis has a significant effect on low back pain (LBP)-related health care visits and costs...